The Precision Peptide Company Inc. (PNGAF)
OTC
0.3145
-0.00095 (-0.30%)
Closed
Aug 24, 2026
Day's Range
0.31450.3400
52 wk Range
0.10000.5000
Financial Statements - PNGAF - The Precision Peptide Company Inc.
Revenue
49.72K▲ 307.5%
Net Income
-4.52M▼ 339.0%Net Margin -9104.3%
EBITDA
121.96K▲ 115.1%
Free Cash Flow
-2.33M▼ 431.1%
Income Statement
| Period Ending | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 |
|---|---|---|---|---|
| Sales | 49.72K | 12.20K | 285.59K | 408.01K |
| Cost of Goods | 27.77K | 5.29K | 318.38K | 379.30K |
| Gross Profit | 21.94K | 6.90K | -32.79K | 28.70K |
 Operating Expense | - | - | - | - |
| Operating Income | -2.25M | -920.70K | -1.64M | -631.53K |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | -2.28M | -110.38K | -16.99K | -160.52K |
| Pre Tax Income | -4.52M | -1.03M | -1.66M | -792.05K |
| Income Tax | - | - | - | - |
| Net Income | -4.52M | -1.03M | -1.66M | -792.05K |
| EPS Basic | -0.21 | -0.15 | -0.05 | -0.04 |
| EPS Diluted | -0.21 | -0.15 | -0.05 | -0.04 |
| Basic Shares Outstanding | 21.65M | 6.68M | 49.25M | 27.38M |
| Diluted Shares Outstanding | 21.65M | 6.68M | 49.25M | 27.38M |
| Ebit | -2.25M | -920.70K | -1.64M | -631.53K |
| Ebitda | 121.96K | -806.82K | -1.61M | -571.11K |
| Net Income Continuous Operations | -4.52M | -1.03M | -1.66M | -792.05K |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
